Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryHbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS).Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteriaC-reactive protein and gamma-glutamyltransferase concentrations in relation to the prevalence of type 2 diabetes diagnosed by glucose or HbA1c criteria in Chinese adults in Qingdao, China.Prevalence of cardiovascular risk factors among truck drivers in the South of BrazilThe relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study.Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos.Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China.Diabetes Complications at Presentation and One Year by Glycated Haemoglobin at Diagnosis in a Multiethnic and Diverse Socioeconomic Population: Results from the South London Diabetes Study.Prevalence of Diabetes on Santa Cruz Island in Galapagos Archipelago.Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects.The Utility of HbA1c as a Diagnostic Criterion of Diabetes.Cutoff Point of HbA1c for Diagnosis of Diabetes Mellitus in Chinese Individuals.Ethnicity modifies the relation between fasting plasma glucose and HbA1c in Indians, Malays and Chinese.Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance.Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adultsPerformance of HbA1c and fasting plasma glucose in screening for diabetes in patients undergoing coronary angiography.The pros and cons of diagnosing diabetes with A1CMore Than Just Accuracy: A Novel Method to Incorporate Multiple Test Attributes in Evaluating Diagnostic Tests Including Point of Care Tests.Ideal glycated hemoglobin cut-off points for screening diabetes and prediabetes in a Chinese population.Periodontitis as a possible early sign of diabetes mellitus.Screening for type 2 diabetes and dysglycemia.Use of high-normal levels of haemoglobin A(1C) and fasting plasma glucose for diabetes screening and for prediction: a meta-analysis.Determinants of lifestyle behavior change to prevent type 2 diabetes in high-risk individuals.Sex and age discrepancy of HbA1c and fetal hemoglobin determined by HPLC in a large Chinese Han population.The impact of new screen-detected and previously known type 2 diabetes on health-related quality of life: a population-based study in Qingdao, China.Performance of HbA1c for the prediction of diabetes in a rural community in Korea.Novel biomarkers for prediabetes, diabetes, and associated complications.Glycated lysine-141 in haptoglobin improves the diagnostic accuracy for type 2 diabetes mellitus in combination with glycated hemoglobin HbA1c and fasting plasma glucosePrevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion.Comparison of the performance of HbA1c and fasting plasma glucose in identifying dysglycaemic status in Chinese high-risk subjects.Comparison of Hemoglobin A1c with Fasting and 2-h Plasma Glucose Tests for Diagnosis of Diabetes and Prediabetes among High-risk South Indians.Can HbA1c replace OGTT for the diagnosis of diabetes mellitus among Chinese patients with impaired fasting glucose?A Single A1C >= 6.5% Accurately Identifies Type 2 Diabetes/Impaired Glucose Tolerance in African Americans.HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes.What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006?Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study.Diagnostic Accuracy of Protein Glycation Sites in Long-Term Controlled Patients with Type 2 Diabetes Mellitus and Their Prognostic Potential for Early Diagnosis.
P2860
Q22241786-0C5FB3B5-2D40-4310-AEA1-D637B05283EDQ33865532-61702BD7-1926-4A1C-BBC4-2B843F6FC4D0Q34084645-7C425DD6-A154-4FA3-AF7A-B8A21FE567ADQ34153462-A4E31F1D-9A14-453E-8D9C-188F94B0E1B0Q34289757-0F49977A-AA10-4F79-9D3B-7EF9A65F8FA9Q34409801-9C821DCA-571B-414C-8835-3B155B808855Q34718244-FB833D25-EB3F-4B85-9BA3-327884FFA4F2Q34873090-8F61E0FA-299C-4C32-AC8C-DC67509049CEQ35191868-3AB7F205-0A7D-4C9A-9A61-6119A99CF975Q35671852-D6C28558-7C10-4BC2-8DC1-EB4A37917ED3Q35758735-C599F2CF-238C-455F-8AE9-0BE98F88E5E2Q35774506-2ADCF9FE-F4BA-403D-9517-B95E7D0EE90DQ36058401-13B8F59A-6956-4B61-A842-D5C4F34F1C03Q36197527-EFAA8782-74D5-4331-83D4-567DAEE89CE6Q36417779-DFE8C4DA-363E-4C6C-8C25-C1708404E0C9Q36426675-1B8F99BE-5552-4AFD-B9C2-DC9A2FFB4952Q36705653-C4AC2519-1C71-4C86-927C-77EE1EE57D4BQ36782837-A78E8535-74D7-42EE-AB8A-048549F6DFF0Q36783754-997D1FC9-07BA-4937-9544-5CFF2F1A806CQ37193879-8806493D-EA00-4E0B-8BF4-B8ECEF625D2BQ37227381-A0D21539-C3ED-41A0-A4AC-63634612A19AQ37681311-0D30D888-54D0-4095-B826-74B64F20667DQ37882225-BB0AC4E6-0D0A-4D7F-8AC0-87FD07062B1CQ38130468-418130BF-D084-401B-AF96-0AE76A2DB7DBQ38729525-513F3680-9B44-4904-8FDB-209FBE443EADQ38931610-51C407A8-DF36-4A08-8ABE-2F174D9362C2Q40180649-0F4F6183-66E2-4C22-A0CF-1DB95D52220DQ40951844-028146E7-0CC6-49DE-B317-935540654493Q41475816-1C1F301B-EA5A-4338-B967-847FB84035CEQ42028224-50AA0416-AA33-4A0E-9788-479C43316AB4Q44326569-8B803172-170E-44DB-8A19-72FD2A34B622Q46573671-A6B94074-FB58-4630-95C6-B023ECA169FDQ51245367-EE593150-1982-46CF-905C-B07711806BAFQ51295490-B24661D3-E0DA-43D6-B90E-3266D6CE4617Q51338515-50D9CF5B-E89B-4AAE-A60E-17447B18D2D1Q51367278-082ED8A4-27F0-432E-8B66-0500D9CE614DQ51367301-91223510-15A3-4568-9CEF-47D0C23C91CBQ51375122-1644F6EA-6D76-4454-A179-7CC13254725FQ51386588-8FF37117-E982-4CCE-B11E-190C91B3EB2FQ55645648-659FB36B-2030-411B-9BF6-93CAF8EE445D
P2860
Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Performance of an A1C and fast ...... lerance test in Qingdao, China
@ast
Performance of an A1C and fast ...... lerance test in Qingdao, China
@en
type
label
Performance of an A1C and fast ...... lerance test in Qingdao, China
@ast
Performance of an A1C and fast ...... lerance test in Qingdao, China
@en
prefLabel
Performance of an A1C and fast ...... lerance test in Qingdao, China
@ast
Performance of an A1C and fast ...... lerance test in Qingdao, China
@en
P2093
P2860
P356
P1433
P1476
Performance of an A1C and fast ...... lerance test in Qingdao, China
@en
P2093
Shaojie Wang
Weiguo Gao
Xianghai Zhou
Zengchang Pang
P2860
P304
P356
10.2337/DC09-1410
P407
P577
2009-12-10T00:00:00Z